Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (5.387)

1

Ramucirumab as a second line therapy for advanced HCC : a significant achievement or a wasted opportunity for personalised therapy?

enthalten in: Investigational new drugs | 2019

von Roviello, G. | Sohbani, N. | Petrioli, R. | +1

2

enthalten in: Annales de dermatologie et de venereologie | 2019

von Lacour, J.

3

Lanadelumab for the treatment of hereditary angioedema

enthalten in: Expert opinion on biological therapy | 2019

von Wu, M.

4

The safety of belimumab for the treatment of systemic lupus erythematosus

enthalten in: Expert opinion on drug safety | 2019

von Wise, L. | Stohl, W.

5

Ocular Co-Morbidities of Atopic Dermatitis. Part II : Ocular Disease Secondary to Treatments

enthalten in: American journal of clinical dermatology | 2019

von Beck, K. | Seitzman, G. | Yang, E. | +2

6

A New Era in the Treatment of Thyroid Eye Disease

enthalten in: American journal of ophthalmology | 2019

von Patel, A. | Yang, H. | Douglas, R.

7

Brolucizumab : First Approval

enthalten in: Drugs | 2019

von Markham, A.

8

Novel Therapies in Acute Myeloid Leukemia

enthalten in: Seminars in oncology nursing | 2019

von Mukherjee, S. | Sekeres, M.

9

Immunotherapy for cardiovascular disease

enthalten in: European heart journal | 2019

von Lutgens, E. | Atzler, D. | Döring, Y. | +3

10

Psoriatic Arthritis : Newer and Older Therapies

enthalten in: Current rheumatology reports | 2019

von Chao, R. | Kavanaugh, A.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[539]